← Leaderboards
Javier Gonzãlez-Maeso
Icahn School Of Medicine At Mount Sinai
$8,339,334
Attributed
$8,339,334
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $817.3K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,339,334 · 3
By mechanism
R01$7,916,861 · 2
R56$422,473 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Audrey Louise Warren$85,426
Others in their field
Top investigators on “Receptor”
- Barton F Haynes · Duke University$182,835,224
- James C. Paulson · Scripps Research Institute$84,068,192
- Asrar B. Malik · University Of Illinois At Chicago$55,280,031
- Anthony O Caggiano · Cognition Therapeutics, Inc.$49,563,751
- Robert J Coffey · Vanderbilt University$48,115,270
- Robert H Vonderheide · University Of Pennsylvania$48,030,034
Research focus
ReceptorAgonistBehaviorMental DisordersMolecularSignal TransductionAffectSerotoninPharmaceutical PreparationsResponseMediatingBaseNeuronsComplexFrontal LobeIn VitroBehavioralBrainCellsG-Protein-Coupled ReceptorsStructurePathway InteractionsMetabotropic Glutamate Receptor 2Psychotic Disorders
Grant awards (21)
Function of GPCR heteromeric complexes in brain$447,909
R01 · FY2025 · MH · contact PI
Structure and function of GPCR heteromeric complexes in brain$465,139
R01 · FY2023 · MH · contact PI
Structure and function of GPCR heteromeric complexes in brain$465,139
R01 · FY2022 · MH · contact PI
Structure and function of GPCR heteromeric complexes in brain$465,139
R01 · FY2021 · MH · contact PI
Preclinical role of HDAC2 in mGlu2-dependent schizophrenia treatment$310,002
R01 · FY2021 · MH · contact PI
Structure and function of GPCR heteromeric complexes in brain$471,550
R01 · FY2020 · MH · contact PI
Preclinical role of HDAC2 in mGlu2-dependent schizophrenia treatment$320,440
R01 · FY2020 · MH · contact PI
Structure and function of GPCR heteromeric complexes in brain$512,318
R01 · FY2019 · MH · contact PI
Preclinical role of HDAC2 in mGlu2-dependent schizophrenia treatment$305,000
R01 · FY2019 · MH · contact PI
Structure and function of the 5HT2A-mGlu2 heteromer in schizophrenia$361,782
R01 · FY2018 · MH · contact PI
Preclinical role of HDAC2 in mGlu2-dependent schizophrenia treatment$305,000
R01 · FY2018 · MH · contact PI
Structure and function of the 5HT2A-mGlu2 heteromer in schizophrenia$362,048
R01 · FY2017 · MH · contact PI
Preclinical role of HDAC2 in mGlu2-dependent schizophrenia treatment$305,000
R01 · FY2017 · MH · contact PI
Structure and function of the 5HT2A-mGlu2 heteromer in schizophrenia$362,494
R01 · FY2016 · MH · contact PI
Structure and function of the 5HT2A-mGlu2 heteromer in schizophrenia$368,643
R01 · FY2015 · MH · contact PI
Structure and function of the 5HT2A-mGlu2 heteromer in schizophrenia$422,473
R56 · FY2014 · MH · contact PI
Structure and function of the 5HT2A/mGluR2 complex in schizophrenia$402,732
R01 · FY2013 · MH · contact PI
Structure and function of the 5HT2A/mGluR2 complex in schizophrenia$419,513
R01 · FY2012 · MH · contact PI
Structure and function of the 5HT2A/mGluR2 complex in schizophrenia$419,513
R01 · FY2011 · MH · contact PI
Structure and function of the 5HT2A/mGluR2 complex in schizophrenia$423,750
R01 · FY2010 · MH · contact PI
Structure and function of the 5HT2A/mGluR2 complex in schizophrenia$423,750
R01 · FY2009 · MH · contact PI